{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:38:37Z","timestamp":1782959917838,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jneuroim.2021.577653","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:15:16Z","timestamp":1625098516000},"page":"577653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review"],"prefix":"10.1016","volume":"358","author":[{"given":"Grace Y.","family":"Gombolay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Gadde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2021.577653_bb0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","article-title":"Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis","volume":"85","author":"Absinta","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000343","article-title":"Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder","volume":"4","author":"Asgari","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577653_bb0015","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamaneurol.2020.0001","article-title":"Unilateral leptomeningeal enhancement in myelin oligodendrocyte glycoprotein immunoglobulin G-associated disease","volume":"77","author":"Budhram","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies","volume":"88","author":"Fujimori","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577653_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/08830738211025867","article-title":"Rate of leptomeningeal enhancement in pediatric myelin oligodendrocyte glycoprotein (MOG) antibody associated disorder","author":"Gadde","year":"2021","journal-title":"J. Child Neurol"},{"key":"10.1016\/j.jneuroim.2021.577653_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11940-018-0502-9","article-title":"Pediatric neuromyelitis optica spectrum disorders","volume":"20","author":"Gombolay","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","article-title":"Treatment approaches for MOG-ab-associated demyelination in children","volume":"21","author":"Hacohen","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.msard.2019.06.010","article-title":"Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: a case study","volume":"34","author":"Haddad","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0050","article-title":"A young woman with seizures, visual impairment, and paralysis","volume":"139","author":"Hoglund","year":"2019","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2021.577653_bb0060","doi-asserted-by":"crossref","first-page":"102050","DOI":"10.1016\/j.msard.2020.102050","article-title":"MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy","volume":"41","author":"Leinert","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0065","first-page":"1365175","article-title":"Leptomeningeal and intraparenchymal blood barrier disruption in a MOG-IgG-positive patient","volume":"2018","author":"Mohseni","year":"2018","journal-title":"Case Rep. Neurol. Med."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0070","doi-asserted-by":"crossref","first-page":"476960","DOI":"10.1016\/j.jneuroim.2019.05.001","article-title":"MOG antibody seropositive aseptic meningitis: a new clinical phenotype","volume":"333","author":"Nagabushana","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.msard.2017.07.023","article-title":"A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection","volume":"17","author":"Nakamura","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0085","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-019-09586-5","article-title":"MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity","volume":"267","author":"Papathanasiou","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/clim.1998.4684","article-title":"Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice","volume":"91","author":"Perrin","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577653_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11916-017-0635-7","article-title":"Recurrent meningitis","volume":"21","author":"Rosenberg","year":"2017","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0115","doi-asserted-by":"crossref","first-page":"102013","DOI":"10.1016\/j.msard.2020.102013","article-title":"Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare","volume":"41","author":"Shi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0120","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.2169\/internalmedicine.2845-19","article-title":"Aseptic meningitis as an initial manifestation of anti-myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"58","author":"Suzuki","year":"2019","journal-title":"Intern. Med."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0125","series-title":"American Academy of Neurology Meeting, Boston, Massachusetts. April 22\u201328","article-title":"Steroid responsive anti-MOG antibody mediated meningo-encephalomyelitis and optic neuritis","author":"Truong","year":"2017"},{"key":"10.1016\/j.jneuroim.2021.577653_bb0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pediatrneurol.2020.02.009","article-title":"A stroke mimic: anti-MOG antibody-associated disorder presenting as acute hemiparesis","volume":"108","author":"Tutmaher","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577653_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12883-019-1324-4","article-title":"Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome","volume":"19","author":"Zhong","year":"2019","journal-title":"BMC Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:51Z","timestamp":1759048851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821001806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":27,"alternative-id":["S0165572821001806"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577653","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577653"}}